GIORGI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 9.746
AS - Asia 5.985
EU - Europa 4.580
SA - Sud America 559
AF - Africa 219
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.109
Nazione #
US - Stati Uniti d'America 9.418
CN - Cina 1.791
SG - Singapore 1.582
IT - Italia 1.506
VN - Vietnam 793
SE - Svezia 732
HK - Hong Kong 701
DE - Germania 582
BR - Brasile 496
BG - Bulgaria 338
KR - Corea 321
GB - Regno Unito 302
TR - Turchia 267
CA - Canada 266
FR - Francia 211
UA - Ucraina 201
FI - Finlandia 185
RU - Federazione Russa 162
IN - India 148
CH - Svizzera 134
JP - Giappone 101
CI - Costa d'Avorio 78
BD - Bangladesh 59
GR - Grecia 56
AT - Austria 43
NG - Nigeria 38
IQ - Iraq 36
BE - Belgio 32
MX - Messico 31
IR - Iran 23
PK - Pakistan 23
ZA - Sudafrica 23
SN - Senegal 22
PL - Polonia 21
SA - Arabia Saudita 21
NL - Olanda 20
ID - Indonesia 19
AR - Argentina 18
MA - Marocco 14
UZ - Uzbekistan 13
VE - Venezuela 13
ES - Italia 12
EC - Ecuador 10
EU - Europa 9
AU - Australia 8
KZ - Kazakistan 8
NP - Nepal 8
CR - Costa Rica 7
EG - Egitto 7
IE - Irlanda 7
KE - Kenya 7
OM - Oman 7
PH - Filippine 7
JO - Giordania 6
KG - Kirghizistan 6
LT - Lituania 6
MY - Malesia 6
TW - Taiwan 6
BJ - Benin 5
CG - Congo 5
DZ - Algeria 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
ET - Etiopia 4
HU - Ungheria 4
PY - Paraguay 4
YE - Yemen 4
AL - Albania 3
BB - Barbados 3
BH - Bahrain 3
CY - Cipro 3
EE - Estonia 3
IL - Israele 3
LB - Libano 3
PE - Perù 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IS - Islanda 2
KN - Saint Kitts e Nevis 2
LC - Santa Lucia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
Totale 21.084
Città #
Woodbridge 1.171
Ann Arbor 1.007
Singapore 885
Ashburn 814
Houston 767
Milan 758
Chandler 700
Hong Kong 681
Santa Clara 562
Hefei 434
Fairfield 426
San Jose 416
Dong Ket 391
Beijing 349
Sofia 338
Dallas 310
Seoul 291
Jacksonville 240
Shanghai 229
Ottawa 206
Wilmington 203
Seattle 173
Izmir 172
Cambridge 171
New York 169
Chicago 164
Los Angeles 152
Boardman 133
Princeton 127
Lawrence 117
Ho Chi Minh City 113
Medford 110
Nanjing 109
Lauterbourg 101
Hanoi 94
Bern 93
Tokyo 91
Abidjan 78
Des Moines 66
Jüchen 63
London 62
Alessandria 56
Rome 55
Serra 55
Dearborn 53
The Dalles 52
Buffalo 51
Florence 51
Columbus 49
Istanbul 47
Helsinki 42
Munich 42
Boulder 40
Bremen 40
Zurich 40
Nanchang 38
Council Bluffs 37
Lagos 37
Vienna 36
Redondo Beach 35
Redwood City 33
Frankfurt am Main 32
Lancaster 32
Marseille 32
Ogden 32
São Paulo 32
Brussels 31
Hyderabad 31
Kocaeli 29
Sacile 29
Kunming 27
North York 26
Paris 26
San Diego 26
Shenyang 26
Düsseldorf 24
Fuzhou 23
Pune 23
Dakar 22
Guangzhou 22
Da Nang 20
Hebei 19
Rio de Janeiro 19
Grafing 18
Baghdad 17
Jiaxing 17
Tianjin 17
Dhaka 16
Haiphong 15
Orem 15
Verona 15
Belo Horizonte 14
Changsha 14
Falls Church 14
Hangzhou 14
Warsaw 13
Chennai 12
Jakarta 12
Johannesburg 12
Nürnberg 12
Totale 15.255
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 391
1,2,3-Triazole[4,5-d]pyridazines II. New Derivatives Tested on the Adenosine Receptors 344
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 334
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 323
1,2,3 Triazolo[1,2-a]benzotriazoles or 2,3-Benzo-1,3a,6,6a-Tetraazapentalenes 320
An 1,2,3-Triazole Derivative Bioisoster of a Potent in Vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 319
1,2,3-triazolo [4,5-d] pyridazines-V. Preparation and adenosine receptor binding of new 4-amino derivatives. 311
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 291
1,2,3-TRIAZOLO[4,5-e]-1,2,4-TRIAZOLO[3,4-c]PYRIMIDINES 282
N(6)-SUBSTITUTED 2-PHENYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR - A COMPARISON WITH 2-N-BUTYL ANALOGOUS DERIVATIVES .5. 281
N(6)-SUBSTITUTED 2-N-BUTYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR .4. 271
1,2,3-TRIAZOLE[4,5-D]PYRIDAZINES .3. SYNTHESIS OF NEW 4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARD ADENOSINE RECEPTORS 271
1,2,3-Triazole[4,5-d]pyridazines IV. Preparation and Adenosine Receptor Binding of New 4-and /or 7-Aminoderivatives 266
1,2,3-Triazolo[4,5-d]-1,2,4-triazolo[4,3-b]pyridazines 264
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 260
1,2,3-TRIAZOLO[4,5-D]PYRIDAZINES. PART VI. NEW 1-SUBSTITUTED-4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARDS A1 AND A2 ADENOSINE RECEPTORS 254
1,2,3-Triazolodiazepine I. Preparation and Benzodiazepine Receptor Binding of 1-Benzyl and 1-Phenethyl-1,2,3-Triazolo[4,5-d][1,4]diazepines 253
1,2,3-triazolo[4,5-d]pyridazines - Part VI. New 1-substituted-4-amino derivatives and their affinity towards A(1) and A(2A) adenosine receptors 249
N(6)-Substituted 2-n-Butyl-9-Benzyl-8-Azaadenines. Affinity for Adenosine A1 and A2 Receptors. IV 248
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 248
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 246
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 244
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 242
N(6)CYCLOALKYL-2-PHENYL-3-DEAZA-8-AZAADENINES: A NEW CLASS OF A1ADENOSINE RECEPTOR LIGANDS. A COMPARISON WITH THE CORRESPONDING ADENINES AND 8-AZAADENINES 236
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 228
"One Pot" Synthesis of 2-Substituted 9-(2'-Hydroxy-3'-aminopropyl)-8-azahypoxanthines and 8-Azaadenines [5-Substituted 3-(2'-Hydroxy-3'-aminopropyl)-7-amino and 7-hyroxy- 3H-1,2,3-triazolo[4,5-d]pyrimidines] 227
Synthesis of New 3-Benzyl-5-Phenyl-7-Alkylaminothiazolo[4,5-d]pyrimidine-2(3H)-Thiones.) 221
N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives.5. 219
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 219
N(6) or N(9) Substituted 2-Phenyl-8-Azaadenines: Affinity for A1 Adenosine Receptors. VII 218
N(9)-substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines 218
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 213
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 212
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 211
Adenosine A1 modulators: a patent update (2008 to present) 211
8-Azapurine nucleus: a versatile scaffold for different targets 201
A QSAR study of A1adenosine receptor antagonists by a new neural network model 199
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 198
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 197
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 191
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 184
New amido derivatives as potential BKCa potassium channel activators. XI 184
In vitro Inhibitors of Prostaglandin Synthesis: (p-Thiosubstituted)-Benzyl Nitrogen Heterocycles 182
Studies on 1,2,3-Triazole Derivatives as in vitro Inhibitors of Prostaglandine Synthesis 181
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 179
Xanthine Oxidase (XO). 4(5)-Aminosubstituted-5(4)-Carboxyamido-1H-1,2,3-Triazoles: a New Class of Monocyclic Triazole Inhibitors 178
1,2,3-Trizoles[4,5-d]piridazines. Analogues of Prostaglandin Synthesis Inhibitors 178
Interaction of an improved model of human A1 adenosine receptor with ligands 175
Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives 175
Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C(2) of the Nucleus of 8-Azahypoxanthine 173
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 173
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 173
3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity 173
Antimicrobial properties of flavonoids. 172
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 171
New 4-(Benzotriazol-1-yl)-1,2,3-triazole derivatives 170
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 169
Evaluation of the Quantitative Contribution of a Phenyl Group on C(2) of 8-Azaadenosine to the Binding with Adenosine Deaminase: a New Synthesis of 8-Azaadenosine. XI. 168
Evaluation of new synthesized “adenine derivatives” molecules as cytokinin-like compounds . 167
Modification of the 1,2,3-Triazole Ring Present in an Effective in vitro Inhibitor of Prostaglandin Synthesis 166
XANTHINE-OXIDASE (XO) - RELATIVE CONFIGURATION OF COMPLEXES FORMED BY THE ENZYME, 2-N-ALKYL-HYPOXANTHINE OR 8-N-ALKYL-HYPOXANTHINE AND 2-N-ALKYL-8-AZAHYPOXANTHINES .12. 166
Synthesis of N(6)-Substituted 2-Phenyl-8-Azaadenosines. Their Affinity for Adenosine A1 and A2 Receptors: a Comparison with the Corresponding 2-Phenyl-9-Benzyl-8-Azaadenines. 166
Structure-Activity Studies on a 1,2,3-Triazole Derivative, a Potent in vitro Inhibitor of Prostaglandin Synthesys: the Role of the Heterocyclic Ring 165
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 164
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 164
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 161
An initial comparison of the content of bitter substances in Cynara Scolymus L. plants obtained from rooted of shoots and micropropagation 160
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 159
Synthesis of New 2-Substituted 9-?-D-Ribofuranosyl-8-Azahypoxanthine 155
Alimentazione e qualità della vita 155
TRIAZOLYLBENZIMIDAZOLTHIONES AND DERIVATIVES OF THE NEW 1,2,3-TRIAZOLO[1,5-A][1,3,5]BENZOTRIAZEPINE HETEROCYCLE 154
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 153
Synthesis and functional evaluation of Adenosine A2A receptor ligand 151
An 1,2,3,Triazole Derivatives Bioisoster of a Potent in vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 149
Synthesis of New 1,2,3-triazolo[1,2-a]benzotriazole derivatives or substituted 2,3-benzo-1,3a,6,6a-tetraazapentalenes. II” 149
Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands 149
New Chiral Inhibitors of Induced Platelet Aggregation: the Enantiomeric Specificity of (R)- and (S)-Methyl and Ethyl Esters of 1-{p-[(1-Hydroxycarbonyl)-ethyloxy]-benzyl}-1H-1,2,3-triazole as a Tool for Determining their Biological Target. 148
A Method for the Synthesis of Racemic and Optically Active 2-Substituted 9-(2',3'-Dihidroxypropyl)-8-Azahypoxanthines and 8-Azaadenines 147
Xanthine Oxidase (XO): Relative Configuration of Complexes Formed by the Enzyme, 2- or 8-n-Alkyl-hypoxanthines and 2-n-Alkyl-8-azahypoxanthines. XII 147
2-ALKYLOXYALKYLTHIOHYPOXANTHINES AS NEW POTENT INHIBITORS OF XANTHINE OXIDASE 144
THERAPEUTIC POTENTIAL OF A1 ADENOSINE RECEPTOR LIGANDS: A SURVEY OF RECENT PATENT LITERATURE 144
SOME STRUCTURAL CHANGES ON TRIAZOLYL-BENZOTRIAZOLES AND TRIAZOLYL-BENZIMIDAZOLONES AS POTENTIAL POTASSIUM CHANNEL ACTIVATORS. III 142
Synthesis and ADA Inhibitory Activity of New 2-Aryl-8-Azaadenosines 141
Xanthine Oxidase (XO). Synthesis of 4(5)-Carbxyamido-5(4)-aminoalkanoyl)amino-1,2,3-triazoles and Their Cyclization to 8-Azahypoxanthines. Evaluation for Inhibition of XO. 138
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 138
NEW 1,2,3-TRIAZOLO[4,5-E]1,2,3-TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES.II 138
Steroeselectivity as an evidence for a double insertion of Antagonists within A1 Adenosine Receptors 137
Synthesis and Biological Evaluation of New Imidazole, Pyrimidine and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase 136
THE NEW DEGREE IN TECHICHE ERBORISTICHE (HERBAL TECHNOLOGY) 134
NEW 5-SUBSTITUTED-1-(2-HYDROXYBENZOYL)-BENZOTRIAZOLES, POTASSIUM CHANNELS ACTIVATORS. IV 133
SUBSTITUTED 1,2,3-TRIAZOLO[1,5-A]QUINAZOLINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS 133
Synthesis of analogs of (±)-EHNA as potent inhibitors of ADA 131
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 130
Chemistry of the Dihydrothiazine Ring Moiety of Cephalosporins. A Route to 3-Formoxymethyl-3-Cephem Derivatives 128
NEW N6-OR N(9)-HYDROXYALKYL SUBSTITUTED 8-AZAADENINES OR ADENINES AS AFFECTIVE A1 ADENOSINE RECEPTOR LIGANDS 128
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 127
A 3D Model of the Human A1 Adenosine Receptor. An Evaluation of the Binding Free-Energy with Ligands 127
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 123
New amino derivatives of 1,2,3-triazolo[4,5-D]pyrimidines and their affinity towards A1 and A2A adenosune receptors 119
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II 118
Totale 19.373
Categoria #
all - tutte 52.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021495 0 0 0 0 0 0 0 0 0 0 46 449
2021/20221.459 16 119 20 110 259 198 15 100 87 14 91 430
2022/20231.873 254 240 118 208 217 239 30 138 304 7 101 17
2023/20242.134 319 238 365 218 313 224 29 56 25 58 44 245
2024/20254.036 46 146 41 212 429 407 286 229 355 455 528 902
2025/20264.360 481 674 518 258 407 395 845 178 230 322 52 0
Totale 21.175